$HR
Healthcare Realty Trust Inc

2014 Q1 Form 10-Q Financial Statement

#000136060414000033 Filed on April 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $91.30M $76.86M
YoY Change 18.79% 8.75%
Cost Of Revenue $32.80M $29.40M
YoY Change 11.56% 3.89%
Gross Profit $57.70M $50.80M
YoY Change 13.58% 6.5%
Gross Profit Margin 63.2% 66.09%
Selling, General & Admin $6.000M $6.500M
YoY Change -7.69% 25.0%
% of Gross Profit 10.4% 12.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $28.00M $18.20M
YoY Change 53.85% 8.98%
% of Gross Profit 48.53% 35.83%
Operating Expenses $32.50M $30.30M
YoY Change 7.26% 7.83%
Operating Profit $19.50M $12.45M
YoY Change 56.57% 19.18%
Interest Expense -$17.80M -$19.50M
YoY Change -8.72% 7.73%
% of Operating Profit -91.29% -156.59%
Other Income/Expense, Net $26.00K $8.000K
YoY Change 225.0% -100.07%
Pretax Income $7.500M $900.0K
YoY Change 733.33% -35.71%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $5.292M $1.351M
YoY Change 291.71% -528.89%
Net Earnings / Revenue 5.8% 1.76%
Basic Earnings Per Share $0.04 $0.01
Diluted Earnings Per Share $0.04 $0.01
COMMON SHARES
Basic Shares Outstanding 118.6M shares 217.1M shares
Diluted Shares Outstanding 119.9M shares 218.9M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.20M $94.20M
YoY Change -89.17% 1327.27%
Cash & Equivalents $27.36M $121.0M
Short-Term Investments
Other Short-Term Assets $9.000M $7.000M
YoY Change 28.57% -84.41%
Inventory
Prepaid Expenses
Receivables $21.00M $18.00M
Other Receivables $53.00M $0.00
Total Short-Term Assets $10.20M $94.20M
YoY Change -89.17% 4.32%
LONG-TERM ASSETS
Property, Plant & Equipment $2.454B $2.217B
YoY Change 10.72% -1.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.20M $22.30M
YoY Change -54.26% -16.79%
Total Long-Term Assets $2.725B $2.496B
YoY Change 9.18% 5.44%
TOTAL ASSETS
Total Short-Term Assets $10.20M $94.20M
Total Long-Term Assets $2.725B $2.496B
Total Assets $2.735B $2.590B
YoY Change 5.6% 5.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.70M $45.50M
YoY Change 11.43% -3.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.70M $45.50M
YoY Change 11.43% -3.19%
LONG-TERM LIABILITIES
Long-Term Debt $1.388B $1.415B
YoY Change -1.9% -0.25%
Other Long-Term Liabilities $60.40M $58.00M
YoY Change 4.14% 10.9%
Total Long-Term Liabilities $1.449B $1.473B
YoY Change -1.66% 0.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.70M $45.50M
Total Long-Term Liabilities $1.449B $1.473B
Total Liabilities $1.360B $1.245B
YoY Change 9.31% 35.56%
SHAREHOLDERS EQUITY
Retained Earnings -$770.9M -$664.6M
YoY Change 15.99% 30.55%
Common Stock $2.130B $1.991B
YoY Change 6.97% -2.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.359B $1.329B
YoY Change
Total Liabilities & Shareholders Equity $2.735B $2.590B
YoY Change 5.6% 5.4%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $5.292M $1.351M
YoY Change 291.71% -528.89%
Depreciation, Depletion And Amortization $28.00M $18.20M
YoY Change 53.85% 8.98%
Cash From Operating Activities $33.45M $27.94M
YoY Change 19.73% 7.02%
INVESTING ACTIVITIES
Capital Expenditures -$15.90M -$25.00M
YoY Change -36.4% -43.82%
Acquisitions
YoY Change
Other Investing Activities -$600.0K -$23.20M
YoY Change -97.41% -168.64%
Cash From Investing Activities -$5.966M -$92.13M
YoY Change -93.52% -58.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $572.0K -$105.5M
YoY Change -100.54% -1163.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$18.21M $169.2M
YoY Change -110.76% 5.52%
NET CHANGE
Cash From Operating Activities $33.45M $27.94M
Cash From Investing Activities -$5.966M -$92.13M
Cash From Financing Activities -$18.21M $169.2M
Net Change In Cash $9.278M $105.0M
YoY Change -91.16% -405.5%
FREE CASH FLOW
Cash From Operating Activities $33.45M $27.94M
Capital Expenditures -$15.90M -$25.00M
Free Cash Flow $49.35M $52.94M
YoY Change -6.78% -25.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
78973000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
82893000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2127709000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2126897000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4323000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1388000 USD
CY2013Q1 us-gaap Amortization Of Deferred Leasing Fees
AmortizationOfDeferredLeasingFees
583000 USD
CY2014Q1 us-gaap Amortization Of Deferred Leasing Fees
AmortizationOfDeferredLeasingFees
874000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1299000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
966000 USD
CY2014Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
63000 USD
CY2013Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
67000 USD
CY2013Q4 us-gaap Assets
Assets
2752334000 USD
CY2014Q1 us-gaap Assets
Assets
2735246000 USD
CY2014Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2272000 USD
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1696000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18081000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27359000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15956000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120958000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9278000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
105002000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2369000 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
2373000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
64408000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
71806000 USD
CY2014Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1231775000 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1213676000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-565000 USD
CY2014Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-507000 USD
CY2014Q1 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
13843000 USD
CY2013Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
13500000 USD
CY2013Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10921000 USD
CY2014Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11032000 USD
CY2014Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
49904000 USD
CY2013Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
47317000 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34942000 USD
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28561000 USD
CY2014Q1 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
800000 USD
CY2014Q1 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
1989000 USD
CY2013Q4 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
2078000 USD
CY2014Q1 us-gaap Derivative Assets
DerivativeAssets
2215000 USD
CY2013Q4 us-gaap Derivative Assets
DerivativeAssets
2995000 USD
CY2014Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
4204000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
5073000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
5053000 USD
CY2014Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
5025000 USD
CY2013Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2975000 USD
CY2014Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
3036000 USD
CY2014Q1 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
1989000 USD
CY2013Q4 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
2078000 USD
CY2014Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
29589000 USD
CY2013Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
23969000 USD
CY2014Q1 us-gaap Dividends
Dividends
34459000 USD
CY2013Q1 us-gaap Dividends
Dividends
32518000 USD
CY2014Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
34148000 USD
CY2013Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
32333000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2014Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P16Y
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6299000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6448000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
163553000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
151860000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
476296000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
474442000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
324436000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
310889000 USD
CY2013 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P15Y10M24D
CY2014Q1 us-gaap Incentive To Lessee
IncentiveToLessee
708000 USD
CY2013Q4 us-gaap Incentive To Lessee
IncentiveToLessee
771000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
76000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
58000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1331000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4168000 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1739000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5428000 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-143000 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
396000 USD
CY2013Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11318000 USD
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11904000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
8235000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
10212000 USD
CY2014Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2363386000 USD
CY2013Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2358071000 USD
CY2014Q1 us-gaap Land
Land
203014000 USD
CY2013Q4 us-gaap Land
Land
203001000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
1360481000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
1349323000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2735246000 USD
CY2014Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
5390000 USD
CY2013Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1351000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2752334000 USD
CY2014Q1 us-gaap Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest
LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
0.9894
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
1214241000 USD
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
1232282000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
540528000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
312993000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
100948000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
197496000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
73982000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5828000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
12543000 USD
CY2014Q1 us-gaap Minority Interest
MinorityInterest
12292000 USD
CY2014Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare Trust of America, Inc., a Maryland corporation, and Healthcare Trust of America Holdings, LP, a Delaware limited partnership, were incorporated or formed, as applicable, on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;20, 2006</font><font style="font-family:inherit;font-size:10pt;">. Healthcare Trust of America, Inc., or HTA, operates as a real estate investment trust, or REIT, and is the general partner of Healthcare Trust of America Holdings, LP, or HTALP, which is the operating partnership. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, HTA owned a </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">98.94%</font><font style="font-family:inherit;font-size:10pt;"> partnership interest and other limited partners, including some of HTA&#8217;s directors, executive officers and their affiliates, owned the remaining partnership interest (including the long term incentive plan, or LTIP, units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP&#8217;s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA&#8217;s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debts of HTALP. HTALP conducts the operations of the business and has no publicly traded equity. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HTA is a fully integrated, self-administered and internally managed REIT and is one of the largest publicly-traded REITs focused on medical office buildings in the United States based on gross leasable area, or GLA. We are primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, (ii) actively manage our balance sheet to maintain flexibility with conservative leverage, and (iii) seek internal growth through proactive asset management, leasing and property management oversight. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT. </font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.0 billion</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, our portfolio consisted of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">269</font><font style="font-family:inherit;font-size:10pt;"> medical office buildings and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">19</font><font style="font-family:inherit;font-size:10pt;"> other facilities that serve the healthcare industry, as well as real estate notes receivable secured by medical office buildings.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.</font></div></div>
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
169190000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18205000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92125000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5966000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27937000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33449000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
5292000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
1351000 USD
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
142000 USD
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000 USD
CY2014Q1 us-gaap Notes Receivable Net
NotesReceivableNet
28520000 USD
CY2013Q4 us-gaap Notes Receivable Net
NotesReceivableNet
28520000 USD
CY2014Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0 Acquisitions
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
19498000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12453000 USD
CY2014Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
410076000 USD
CY2013Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
411857000 USD
CY2014Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
49277000 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
50343000 USD
CY2013Q4 us-gaap Other Liabilities
OtherLiabilities
35339000 USD
CY2014Q1 us-gaap Other Liabilities
OtherLiabilities
32802000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
272000 USD
CY2014Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
572000 USD
CY2013Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2179000 USD
CY2014Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1077000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30856000 USD
CY2014Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
34052000 USD
CY2013Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
348000 USD
CY2014Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
475000 USD
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3739000 USD
CY2014Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5570000 USD
CY2013Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
88529000 USD
CY2014Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
9156000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6683000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
105749000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
297558000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
0 USD
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
103000000 USD
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
1384000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
5434000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
99000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-174000 USD
CY2013Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
445938000 USD
CY2014Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
477487000 USD
CY2013Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2972929000 USD
CY2014Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2976476000 USD
CY2014Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2498989000 USD
CY2013Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2526991000 USD
CY2014Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
90452000 USD
CY2013Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
76241000 USD
CY2014Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3269000 USD
CY2013Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3262000 USD
CY2014Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000 USD
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
175000000 USD
CY2014Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1901000 USD
CY2013Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
127175000 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
18510000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
18114000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-770878000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-742060000 USD
CY2014Q1 us-gaap Revenues
Revenues
91304000 USD
CY2013Q1 us-gaap Revenues
Revenues
76861000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1343656000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1264595000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1388000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4323000 USD
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104558000 USD
CY2014Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
100000000.0 USD
CY2014Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
572000 USD
CY2013Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
272000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1387206000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
1359204000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1399749000 USD
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1371496000 USD
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1606000 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-841000 USD
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1801000 shares
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2536000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239823000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218904000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217103000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237287000 shares
CY2013Q4 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
22847000 USD
CY2014Q1 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
20601000 USD
CY2014Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
976000 USD
CY2013Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
1025000 USD
CY2013Q1 hta Adjustments To Redeemable Noncontrolling Interests
AdjustmentsToRedeemableNoncontrollingInterests
1619000 USD
CY2014Q1 hta Depreciation Amortizationand Other
DepreciationAmortizationandOther
34111000 USD
CY2013Q1 hta Depreciation Amortizationand Other
DepreciationAmortizationandOther
28564000 USD
CY2014Q1 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
0 USD
CY2013Q1 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
1195000 USD
CY2014Q1 hta Equity Offering Program Authorized Amount
EquityOfferingProgramAuthorizedAmount
300000000 USD
CY2014Q1 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
6422000 USD
CY2013Q4 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
6019000 USD
CY2014Q1 hta Finite Lived Intangible Liabilities Gross
FiniteLivedIntangibleLiabilitiesGross
17821000 USD
CY2013Q4 hta Finite Lived Intangible Liabilities Gross
FiniteLivedIntangibleLiabilitiesGross
17816000 USD
CY2014Q1 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
11399000 USD
CY2013Q4 hta Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
11797000 USD
CY2013 hta Finite Lived Intangible Liabilities Weighted Average Remaining Life
FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife
P18Y4M24D
CY2014Q1 hta Finite Lived Intangible Liabilities Weighted Average Remaining Life
FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife
P18Y6M
CY2014Q1 hta Inceptionto Date Acquisition Purchase Price
InceptiontoDateAcquisitionPurchasePrice
3000000000 USD
CY2014Q1 hta Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities
IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities
2517000 USD
CY2013Q1 hta Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities
IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities
457000 USD
CY2014Q1 hta Interest Expense Derivative Financial Instruments
InterestExpenseDerivativeFinancialInstruments
1345000 USD
CY2013Q1 hta Interest Expense Derivative Financial Instruments
InterestExpenseDerivativeFinancialInstruments
1365000 USD
CY2014Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
2186000 USD
CY2013Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
-241000 USD
CY2014Q1 hta Interest Incomefrom Real Estate Notes Receivableand Other Income
InterestIncomefromRealEstateNotesReceivableandOtherIncome
852000 USD
CY2013Q1 hta Interest Incomefrom Real Estate Notes Receivableand Other Income
InterestIncomefromRealEstateNotesReceivableandOtherIncome
620000 USD
CY2014Q1 hta Listing Expense
ListingExpense
0 USD
CY2013Q1 hta Listing Expense
ListingExpense
4405000 USD
CY2013Q1 hta Noncash Debt Issuance Costs
NoncashDebtIssuanceCosts
528000 USD
CY2014Q1 hta Noncash Debt Issuance Costs
NoncashDebtIssuanceCosts
0 USD
CY2013Q4 hta Note Receivable Tenant
NoteReceivableTenant
3173000 USD
CY2014Q1 hta Note Receivable Tenant
NoteReceivableTenant
3143000 USD
CY2013Q1 hta Numberof Real Estate Properties Heldforsale
NumberofRealEstatePropertiesHeldforsale
1 property
CY2014Q1 hta Offering Costs Transferred To Equity
OfferingCostsTransferredToEquity
0 USD
CY2013Q1 hta Offering Costs Transferred To Equity
OfferingCostsTransferredToEquity
1191000 USD
CY2013Q1 hta Paymentof Earnout
PaymentofEarnout
92000 USD
CY2014Q1 hta Paymentof Earnout
PaymentofEarnout
375000 USD
CY2014Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
247000 USD
CY2013Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
0 USD
CY2013Q4 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
110285000 USD
CY2014Q1 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
112591000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001360604
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
237303146 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRUST OF AMERICA, INC.

Files In Submission

Name View Source Status
0001360604-14-000033-index-headers.html Edgar Link pending
0001360604-14-000033-index.html Edgar Link pending
0001360604-14-000033.txt Edgar Link pending
0001360604-14-000033-xbrl.zip Edgar Link pending
a2014331ex105.htm Edgar Link pending
a2014331ex311.htm Edgar Link pending
a2014331ex312.htm Edgar Link pending
a2014331ex313.htm Edgar Link pending
a2014331ex314.htm Edgar Link pending
a2014331ex321.htm Edgar Link pending
a2014331ex322.htm Edgar Link pending
a2014331ex323.htm Edgar Link pending
a2014331ex324.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hta-20140331.xml Edgar Link completed
hta-20140331.xsd Edgar Link pending
hta-20140331_cal.xml Edgar Link unprocessable
hta-20140331_def.xml Edgar Link unprocessable
hta-20140331_lab.xml Edgar Link unprocessable
hta-20140331_pre.xml Edgar Link unprocessable
hta201433110-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending